论文部分内容阅读
[目的]观察安络化纤丸对慢性乙型肝炎肝纤维化指标的影响。[方法]将63例病例分为两组,治疗组35例以安络化纤丸治疗;对照组28例使用护肝片、肝泰乐等保肝药治疗3个月。观察用药前后肝病常规检测,如肝功、影像学,重点观测肝纤维化指标(HA、LN、PCⅢ、IVC)。[结果]治疗组疗效优于对照组(P<0.01)。[结论]安络化纤丸治疗慢性乙型肝炎肝纤维化具有良好的疗效。
[Objective] To observe the effect of Anluohuaxian pill on the indexes of liver fibrosis in chronic hepatitis B patients. [Method] The 63 cases were divided into two groups, 35 cases in the treatment group were treated with Anluo Huaxian Pills; the control group, 28 cases were treated with liver protection tablets and Gantrez for 3 months. Before and after treatment of liver disease routine testing, such as liver function, imaging, focusing on the observation of liver fibrosis indicators (HA, LN, PC Ⅲ, IVC). [Result] The curative effect of treatment group was better than that of control group (P <0.01). [Conclusion] An Luohuaxian pill in treating chronic hepatitis B liver fibrosis has a good effect.